相关实验视频

Updated: Mar 6, 2026

Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor

Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor

Published on: May 2, 2022

超越瘤突变负担:在胃肠道癌症中免疫检查点阻断反应的框架

Kimihiro Yamashita^1,2, Mitsugu Fujita³, Masafumi Saito⁴

¹Department of Biophysics, Graduate School of Health Sciences, Kobe University, 7-10-2, Tomogaoka, Suma-ku, Kobe, Hyogo, 654-0142, Japan. kiyama@med.kobe-u.ac.jp.

International journal of clinical oncology

|March 5, 2026

概括

有效免疫原负荷 (EIB) 提供了一种新的方法来预测胃肠道癌症中对免疫检查点阻塞 (ICB) 的反应. 欧洲投资银行 (EIB) 整合了新抗原的质量和呈现,改善了瘤突变负担 (TMB),以改善患者分层.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
遗传学是一个遗传学.

背景情况:

免疫检查点阻塞 (ICB) 在不匹配修复缺陷 (dMMR) 或微卫星不稳定性高 (MSI-H) 的胃肠道 (GI) 癌症中显示出有效性.
微卫星稳定性胃肠道癌 (MSS) 显示ICB的益处有限,突出了当前预测生物标志物的差距.
瘤突变负担 (TMB) 是ICB响应的不足生物标志物,原因是捕获真正瘤免疫性方面的局限性.

研究的目的:

通过提出一个新的概念框架来解决TMB在预测ICB响应方面的局限性.
整合新抗原质量和抗原呈现能力,以便更准确地评估瘤免疫性.
引入有效免疫原负荷 (EIB) 作为肠道癌症中异质ICB反应的临床可解释的生物标志物.

主要方法:

对体突变的评估及其加工成HLA分子上呈现的.
对抗原呈现途径的评估,包括干扰素不响应和HLA I类表达.
开发有效免疫原体负担 (EIB) 框架,整合新抗原质量和呈现.

主要成果:

一小部分的体质突变产生免疫性,进一步受到抗原呈现缺陷的限制.
高质量的新抗原可能不会引起反应,如果抗原呈现受损.
欧洲投资银行框架整合了新抗原质量和呈现能力,提供了超越TMB的全面视图.

结论:

有效免疫性负担 (EIB) 提供了比TMB更准确的瘤免疫性测量.
欧洲投资银行负责HLA分子的新抗原生成和成功呈现.
这一框架为了解和预测GI癌症中对ICB的不同反应提供了临床相关的基础.

关键词:

抗原呈现方式胃肠道癌症是什么意思免疫检查点封锁封锁新抗原质量的质量.瘤免疫原性瘤免疫原性

更多相关视频

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...